183 related articles for article (PubMed ID: 25839161)
1. Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis.
De Simone V; Ronchetti G; Franzè E; Colantoni A; Ortenzi A; Fantini MC; Rizzo A; Sica GS; Sileri P; Rossi P; MacDonald TT; Pallone F; Monteleone G; Stolfi C
Oncotarget; 2015 Apr; 6(12):9908-23. PubMed ID: 25839161
[TBL] [Abstract][Full Text] [Related]
2. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.
De Simone V; Franzè E; Ronchetti G; Colantoni A; Fantini MC; Di Fusco D; Sica GS; Sileri P; MacDonald TT; Pallone F; Monteleone G; Stolfi C
Oncogene; 2015 Jul; 34(27):3493-503. PubMed ID: 25174402
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of regulatory T cells promotes intestinal tumorigenesis and is associated with decreased NK cells and IL-22 binding protein.
Janakiram NB; Mohammed A; Bryant T; Brewer M; Biddick L; Lightfoot S; Lang ML; Rao CV
Mol Carcinog; 2015 Oct; 54(10):986-98. PubMed ID: 24797894
[TBL] [Abstract][Full Text] [Related]
4. IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.
Oh JH; Cho MC; Kim JH; Lee SY; Kim HJ; Park ES; Ban JO; Kang JW; Lee DH; Shim JH; Han SB; Moon DC; Park YH; Yu DY; Kim JM; Kim SH; Yoon DY; Hong JT
Oncogene; 2011 Jul; 30(30):3345-59. PubMed ID: 21423208
[TBL] [Abstract][Full Text] [Related]
5. The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.
Koblansky AA; Truax AD; Liu R; Montgomery SA; Ding S; Wilson JE; Brickey WJ; Mühlbauer M; McFadden RM; Hu P; Li Z; Jobin C; Lund PK; Ting JP
Cell Rep; 2016 Mar; 14(11):2562-75. PubMed ID: 26971998
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis.
Wang K; Kim MK; Di Caro G; Wong J; Shalapour S; Wan J; Zhang W; Zhong Z; Sanchez-Lopez E; Wu LW; Taniguchi K; Feng Y; Fearon E; Grivennikov SI; Karin M
Immunity; 2014 Dec; 41(6):1052-63. PubMed ID: 25526314
[TBL] [Abstract][Full Text] [Related]
7. RORγt(+) hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice.
Martin M; Kesselring RK; Saidou B; Brunner SM; Schiechl G; Mouris VF; Wege AK; Rümmele P; Schlitt HJ; Geissler EK; Fichtner-Feigl S
Eur J Immunol; 2015 Jun; 45(6):1667-79. PubMed ID: 25820779
[TBL] [Abstract][Full Text] [Related]
8. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model.
Kirchberger S; Royston DJ; Boulard O; Thornton E; Franchini F; Szabady RL; Harrison O; Powrie F
J Exp Med; 2013 May; 210(5):917-31. PubMed ID: 23589566
[TBL] [Abstract][Full Text] [Related]
9. Effects of growth arrest and DNA damage-inducible protein 34 (GADD34) on inflammation-induced colon cancer in mice.
Tanaka Y; Ito S; Oshino R; Chen N; Nishio N; Isobe K
Br J Cancer; 2015 Aug; 113(4):669-79. PubMed ID: 26196182
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner.
Eissmann MF; Dijkstra C; Wouters MA; Baloyan D; Mouradov D; Nguyen PM; Davalos-Salas M; Putoczki TL; Sieber OM; Mariadason JM; Ernst M; Masson F
Cancer Immunol Res; 2018 Apr; 6(4):409-421. PubMed ID: 29463593
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice.
Jauch D; Martin M; Schiechl G; Kesselring R; Schlitt HJ; Geissler EK; Fichtner-Feigl S
Gut; 2011 Dec; 60(12):1678-86. PubMed ID: 21948944
[TBL] [Abstract][Full Text] [Related]
13. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis.
Xiao H; Gulen MF; Qin J; Yao J; Bulek K; Kish D; Altuntas CZ; Wald D; Ma C; Zhou H; Tuohy VK; Fairchild RL; de la Motte C; Cua D; Vallance BA; Li X
Immunity; 2007 Apr; 26(4):461-75. PubMed ID: 17398123
[TBL] [Abstract][Full Text] [Related]
14. Targeted deletion of miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer.
Zou F; Mao R; Yang L; Lin S; Lei K; Zheng Y; Ding Y; Zhang P; Cai G; Liang X; Liu J
FEBS J; 2016 Apr; 283(8):1438-52. PubMed ID: 26859226
[TBL] [Abstract][Full Text] [Related]
15. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity.
Long X; Wong CC; Tong L; Chu ESH; Ho Szeto C; Go MYY; Coker OO; Chan AWH; Chan FKL; Sung JJY; Yu J
Nat Microbiol; 2019 Dec; 4(12):2319-2330. PubMed ID: 31501538
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK
Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444
[TBL] [Abstract][Full Text] [Related]
17. IL-33 activates tumor stroma to promote intestinal polyposis.
Maywald RL; Doerner SK; Pastorelli L; De Salvo C; Benton SM; Dawson EP; Lanza DG; Berger NA; Markowitz SD; Lenz HJ; Nadeau JH; Pizarro TT; Heaney JD
Proc Natl Acad Sci U S A; 2015 May; 112(19):E2487-96. PubMed ID: 25918379
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
19. Sonic hedgehog inhibitors prevent colitis-associated cancer via orchestrated mechanisms of IL-6/gp130 inhibition, 15-PGDH induction, Bcl-2 abrogation, and tumorsphere inhibition.
Kangwan N; Kim YJ; Han YM; Jeong M; Park JM; Go EJ; Hahm KB
Oncotarget; 2016 Feb; 7(7):7667-82. PubMed ID: 26716648
[TBL] [Abstract][Full Text] [Related]
20. Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice.
He Z; He X; Chen Z; Ke J; He X; Yuan R; Cai Z; Chen X; Wu X; Lan P
Oncol Rep; 2014 Nov; 32(5):1873-80. PubMed ID: 25174408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
